Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Guruprasad R. Medigeshi"'
Autor:
Anbalagan Anantharaj, Tanvi Agrawal, Pooja Kumari Shashi, Alok Tripathi, Parveen Kumar, Imran Khan, Madhu Pareek, Balwant Singh, Chitra Pattabiraman, Saurabh Kumar, Rajesh Pandey, Anmol Chandele, Rakesh Lodha, Stephen S. Whitehead, Guruprasad R. Medigeshi
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-15 (2023)
Abstract Background India is hyperendemic to dengue and over 50% of adults are seropositive. There is limited information on the association between neutralizing antibody profiles from prior exposure and viral RNA levels during subsequent infection.
Externí odkaz:
https://doaj.org/article/e27f036701814e108f9e0aa268fe6a38
Autor:
Puneet Misra, Shashi Kant, Randeep Guleria, Mohammad Ahmad, Suprakash Mandal, P. K. Chaturvedi, Guruprasad R. Medigeshi, Suneeta Meena, Sanjay Kumar Rai, Anisur Rahman, Meenu Sangral, Kapil Yadav, Mohan Bairwa, Partha Haldar
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Several methodological tests are available to detect SARS-CoV-2 antibody. Tests are mostly used in the aid of diagnosis or for serological assessment. No tests are fully confirmatory and have variable level of diagnostic ability.
Externí odkaz:
https://doaj.org/article/9999c7ef58ef4922b3987432af3e8674
Autor:
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, Guruprasad R. Medigeshi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
Serosurveillance studies show a heterogenous mix of the Indian population with immunity to COVID-19 due to vaccination or natural infection. Here, the authors enrol subjects representative of the general population, to assess whether pre-existing ant
Externí odkaz:
https://doaj.org/article/9f137a18f4f940adb91abc76b8797ea6
Autor:
Puneet Misra, Arvind Kumar Singh, Baijayantimala Mishra, Bijayini Behera, Binod Kumar Patro, Guruprasad R. Medigeshi, Hari Shanker Joshi, Mohammad Ahmad, Pradeep Kumar Chaturvedi, Palanivel Chinnakali, Partha Haldar, Mohan Bairwa, Pradeep Kharya, Rahul Dhodapkar, Ramashankar Rath, Randeep Guleria, Sanjay Kumar Rai, Sitanshu Sekhar Kar, Shashi Kant, Sonali Sarkar, Subrata Baidya, Suneeta Meena, Suprakash Mandal, Surekha Kishore, Tapan Majumder, Vivek Hada
Publikováno v:
PLoS ONE, Vol 18, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/d2c11753e5ef4100b161cedb575e43af
Autor:
Ankit Gupta, Anjali Anand, Neha Jain, Sandeep Goswami, Anbalagan Anantharaj, Sharanabasava Patil, Rahul Singh, Amit Kumar, Tripti Shrivastava, Shinjini Bhatnagar, Guruprasad R. Medigeshi, Tarun Kumar Sharma
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 321-332 (2021)
The recent SARS-CoV-2 outbreak has been declared a global health emergency. It will take years to vaccinate the whole population to protect them from this deadly virus, hence the management of SARS-CoV-2 largely depends on the widespread availability
Externí odkaz:
https://doaj.org/article/ca1e36a6671540faa47ae00601b90f89
Autor:
Madiha Haider, Dhwani Dholakia, Aleksha Panwar, Parth Garg, Atish Gheware, Dayanidhi Singh, Khushboo Singhal, Shaunak A. Burse, Surekha Kumari, Anmol Sharma, Arjun Ray, Guruprasad R. Medigeshi, Upendra Sharma, Bhavana Prasher, Mitali Mukerji
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Bioactive fractions obtained from medicinal plants which have been used for the treatment of multiple diseases could exert their effects by targeting common pathways. Prior knowledge of their usage could allow us to identify novel molecular
Externí odkaz:
https://doaj.org/article/0175981b65a54ed1aa88679019646841
Autor:
Deepti Maheshwari, Keshav Saini, Prabhat Singh, Mohit Singla, Kaustuv Nayak, Charu Aggarwal, Yadya M. Chawla, Prashant Bajpai, Manpreet Kaur, Sivaram Gunisetty, Christiane S. Eberhardt, Rajni Nyodu, Kathryn Moore, Mehul S. Suthar, Guruprasad R. Medigeshi, Evan Anderson, Rakesh Lodha, Sushil K. Kabra, Rafi Ahmed, Anmol Chandele, Kaja Murali-Krishna
Publikováno v:
iScience, Vol 25, Iss 6, Pp 104384- (2022)
Summary: Monocytes are known to play a critical role in dengue pathophysiology. However, which monocyte subset expresses what inflammatory mediator(s) and what transcriptional features distinguish each of the monocyte subset in vivo remain poorly und
Externí odkaz:
https://doaj.org/article/1706272f5f43403b9acb6d01e7803e19
Autor:
Nitin Dhochak, Tanvi Agrawal, Heena Shaman, Naseem Ahmed Khan, Prawin Kumar, Sushil K. Kabra, Guruprasad R. Medigeshi, Rakesh Lodha
Publikováno v:
Journal of Clinical Virology Plus, Vol 2, Iss 1, Pp 100061- (2022)
Background: SARS-CoV-2 infection in children frequently leads to only asymptomatic and mild infections. It has been suggested that frequent infections due to low-pathogenicity coronaviruses in children, impart immunity against SARS-CoV-2 in this age
Externí odkaz:
https://doaj.org/article/75d5e672c5124ad188ab33babb2e3b92
Autor:
Puneet Misra, Shashi Kant, Randeep Guleria, Sanjay K. Rai, Abhishek Jaiswal, Suprakash Mandal, Guruprasad R. Medigeshi, Mohammad Ahmad, Anisur Rahman, Meenu Sangral, Kapil Yadav, Mohan Bairwa, Partha Haldar, Parveen Kumar
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1312 (2022)
Background: The plaque reduction neutralization test (PRNT) is the gold standard to detect the neutralizing capacity of serum antibodies. Neutralizing antibodies confer protection against further infection. The present study measured the antibody lev
Externí odkaz:
https://doaj.org/article/51dee8087ad945e98e21eddce3acac25
Autor:
Anbalagan Anantharaj, Soon Jyoti Das, Patil Sharanabasava, Rakesh Lodha, Sushil K. Kabra, Tarun Kumar Sharma, Guruprasad R. Medigeshi
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
The gold standard for the diagnosis of SARS-CoV-2, the causative agent of COVID-19, is real-time polymerase chain reaction (PCR), which is labor-intensive, expensive, and not widely available in resource-poor settings. Therefore, it is imperative to
Externí odkaz:
https://doaj.org/article/f950b389befc4c7388f75c31eb8ddb73